Upgrade to SI Premium - Free Trial

Praxis Precision Medicines (PRAX)

257.90 +1.43 (0.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

JPMorgan Starts Praxis Precision Medicines Inc. (PRAX) at Overweight October 15, 2026 4:21 PM - StreetInsider UBS Reiterates Neutral Rating on Praxis Precision Medicines Inc. (PRAX) October 14, 2026 4:45 PM - StreetInsider Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 2, 2026 4:01 PM - Globe NewsWire H.C. Wainwright Reiterates Buy Rating on Praxis Precision Medicines Inc. (PRAX) September 24, 2026 6:44 AM - StreetInsider Praxis Precision Medicines Inc. (PRAX) PT Raised to $575 at Goldman Sachs August 21, 2026 6:29 AM - StreetInsider Praxis Precision Medicines Inc. (PRAX) PT Raised to $945 at Raymond James August 17, 2026 6:15 AM - StreetInsider Form SCHEDULE 13G/A Praxis Precision Medicin Filed by: ORBIS INVESTMENT MANAGEMENT LTD August 14, 2026 2:09 PM - SEC Filing Praxis Precision Medicines Inc. (PRAX) PT Raised to $362 at Wells Fargo August 7, 2026 8:20 AM - StreetInsider Praxis Precision Medicines Inc. (PRAX) PT Raised to $462 at RBC Capital August 7, 2026 7:30 AM - StreetInsider Praxis Precision Medicines Inc. (PRAX) PT Raised to $514 at Baird August 6, 2026 3:50 PM - StreetInsider Form 10-Q Praxis Precision Medicin For: Jun 30 August 6, 2026 8:33 AM - SEC Filing Form 8-K Praxis Precision Medicin For: Aug 06 August 6, 2026 8:32 AM - SEC Filing Praxis Precision Medicines (PRAX) Tops Q2 EPS by 367c August 6, 2026 8:20 AM - StreetInsider Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results August 6, 2026 8:00 AM - Globe NewsWire Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 4, 2026 4:01 PM - Globe NewsWire Praxis Precision Medicines to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026 July 30, 2026 4:01 PM - Globe NewsWire Full Article List